BDBM50438726 CHEMBL2414684

SMILES: Nc1ccnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12

InChI Key: InChIKey=CJEWHTUUJIZSOG-SHTZXODSSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50438726   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438726 (CHEMBL2414684) Show SMILES Nc1ccnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(25.66,-48.71,;25.59,-50.24,;24.22,-50.95,;24.14,-52.49,;25.45,-53.32,;26.82,-52.61,;27.98,-53.64,;29.5,-53.36,;30.23,-52,;29.61,-50.57,;30.65,-49.4,;32.14,-49.71,;33.15,-48.57,;32.66,-47.09,;31.18,-46.82,;30.16,-47.95,;33.7,-45.92,;33.22,-44.48,;34.23,-43.34,;35.72,-43.61,;36.75,-42.46,;38.25,-42.77,;39.29,-41.61,;38.74,-44.22,;36.2,-45.09,;35.19,-46.23,;28.14,-50.17,;27.87,-48.65,;26.89,-51.08,)| Show InChI InChI=1S/C22H25N3O4/c23-18-9-10-24-21-20(18)22(28)25(11-12-29-21)17-7-5-16(6-8-17)15-3-1-14(2-4-15)13-19(26)27/h5-10,14-15H,1-4,11-13H2,(H2,23,24)(H,26,27)/t14-,15-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (DGAT1) (Homo sapiens (Human))	BDBM50438726 (CHEMBL2414684) Show SMILES Nc1ccnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(O)=O)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(25.66,-48.71,;25.59,-50.24,;24.22,-50.95,;24.14,-52.49,;25.45,-53.32,;26.82,-52.61,;27.98,-53.64,;29.5,-53.36,;30.23,-52,;29.61,-50.57,;30.65,-49.4,;32.14,-49.71,;33.15,-48.57,;32.66,-47.09,;31.18,-46.82,;30.16,-47.95,;33.7,-45.92,;33.22,-44.48,;34.23,-43.34,;35.72,-43.61,;36.75,-42.46,;38.25,-42.77,;39.29,-41.61,;38.74,-44.22,;36.2,-45.09,;35.19,-46.23,;28.14,-50.17,;27.87,-48.65,;26.89,-51.08,)| Show InChI InChI=1S/C22H25N3O4/c23-18-9-10-24-21-20(18)22(28)25(11-12-29-21)17-7-5-16(6-8-17)15-3-1-14(2-4-15)13-19(26)27/h5-10,14-15H,1-4,11-13H2,(H2,23,24)(H,26,27)/t14-,15-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	99	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addi...				Bioorg Med Chem 21: 5081-97 (2013) Article DOI: 10.1016/j.bmc.2013.06.045 BindingDB Entry DOI: 10.7270/Q26111RG
					More data for this Ligand-Target Pair